Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization
Publication date
2007
Authors
van Luijn, J.C.F.
Gribnau, F.W.J.
Leufkens, H.G.
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health, SDG 3 - Good Health and Well-being
Citation
van Luijn, J C F, Gribnau, F W J & Leufkens, H G M 2007, 'Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization', British Journal of Clinical Pharmacology, vol. 63, no. 2, pp. 159-162.